The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function

V.B. Schrauwen-Hindeling, M. Mensink, M.K.C. Hesselink, J.-P. Sels, M.E. Kooi, P. Schrauwen

    Research output: Contribution to journalArticleAcademicpeer-review

    40 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)2917-2921
    JournalJournal of Clinical Endocrinology and Metabolism
    Issue number7
    Publication statusPublished - 2008

    Cite this